Mdm2

Mdm2 inhibitors target the Mdm2 protein, which is an E3 ubiquitin ligase that negatively regulates the tumor suppressor p53. Mdm2 promotes the degradation of p53, thereby preventing apoptosis in cells that should undergo cell death. Inhibiting Mdm2 stabilizes p53, enhancing its tumor-suppressing activity and promoting apoptosis in cancer cells. Mdm2 inhibitors are crucial in cancer research and therapy, particularly for cancers with intact p53 pathways. At CymitQuimica, we provide high-quality Mdm2 inhibitors to support your research in cancer biology, apoptosis, and therapeutic development.